Altitude Lab and the Small Business Administration are pleased to announce Horizon, a commercialization program to connect startups to distributors, biopharma partners, and strategic investors in major biotech hubs nationwide, providing education on deal structures while driving awareness of Altitude Lab’s resident startups. The program is funded by a Stage One grant from the SBA, which Altitude Lab secured last week alongside 60 other top incubator and accelerator programs across the country. To help connect and drive Horizon forward, Altitude has formed initial partnerships with industry leaders, including Wilson Sonsini Goodrich and The Utah Innovation Fund, to support its launch this fall.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Largest borrow rate increases among liquid names
- Recursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers Promising Upside
- Recursion Pharmaceuticals appoints Khan as Chief R&D Officer, CCO
- Recursion Pharmaceuticals Welcomes New Director and C-Suite Executive
- Cathie Wood’s ARK Investment buys 372K shares of Recursion Pharmaceuticals today